Rossari Biotech Limited, a speciality chemicals manufacturer providing intelligent and sustainable solutions for customers across industries, has announced Q3 FY22 revenues of Rs. 428.4 crore as against Rs. 210 crore Q3 FY21, growth of 104% whereas profit stood at Rs. 22.5 crore for Q3 FY22 as against Rs. 21.6 crore for Q3 FY21, showing a growth of 4.3%.

Commenting on the performance for the quarter, in a joint statement, Edward Menezes, Promoter & Executive Chairman, and Sunil Chari, Promoter & Managing Director said, “We have delivered steady performance during the quarter despite a challenging inflationary macro-environment. Our HPPC business reported healthy Y-o-Y sales growth supported by stable traction in FMCG, anti-viral & personal hygiene product portfolio volumes. TSC and AHN segments also delivered Y-o-Y topline growth driven by a pickup in demand in domestic and export markets. We are pleased to share that this is the first full quarter of consolidation of our recent acquisitions of Unitop and Tristar in Rossari’s performance. Both these companies delivered growth during the period, which assisted overall performance."

"The raw material situation remained challenging in Q3 as well. In order to offset these persistent raw material pressures, we have been undertaking price hikes wherever possible. However, raw material volatility has impacted our profitability performance during the quarter," says Edward Menezes and Sunil Chari.

"On the business front, our latest acquisition of Romakk Chemicals has now been consolidated with effect from December 01, 2021. The timely integration of Romakk will further strengthen our presence in the textile and Home and Personal Care segment, going forward. The blend of capabilities from all our recent strategic acquisitions will enable us to build presence and gain scale in our key segments, thus accelerating growth for Rossari," commented Edward Menezes and Sunil Chari.

"The specialty chemicals industry in India is fast progressing with multiple strong growth prospects ahead. With a strong balance sheet, adequate manufacturing capacities, and a solid product portfolio, we are well-poised to capitalize on the upcoming opportunities in this space. Furthermore, stabilization of the macro-economic environment will enable us to deliver strong performance, going forward,” added Edward Menezes and Sunil Chari.

The integration of Romakk Chemicals has been successfully completed and going forward this integration will further strengthen Rossari’s presence in the textile and home & personal care segment.